Zylla, J.L.S.; Hoffman, M.M.; Plesselova, S.; Bhattacharya, S.; Calar, K.; Afeworki, Y.; de la Puente, P.; Gnimpieba, E.Z.; Miskimins, W.K.; Messerli, S.M.
Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC). Cancers 2022, 14, 1753.
https://doi.org/10.3390/cancers14071753
AMA Style
Zylla JLS, Hoffman MM, Plesselova S, Bhattacharya S, Calar K, Afeworki Y, de la Puente P, Gnimpieba EZ, Miskimins WK, Messerli SM.
Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC). Cancers. 2022; 14(7):1753.
https://doi.org/10.3390/cancers14071753
Chicago/Turabian Style
Zylla, Jessica L. S., Mariah M. Hoffman, Simona Plesselova, Somshuvra Bhattacharya, Kristin Calar, Yohannes Afeworki, Pilar de la Puente, Etienne Z. Gnimpieba, W. Keith Miskimins, and Shanta M. Messerli.
2022. "Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC)" Cancers 14, no. 7: 1753.
https://doi.org/10.3390/cancers14071753
APA Style
Zylla, J. L. S., Hoffman, M. M., Plesselova, S., Bhattacharya, S., Calar, K., Afeworki, Y., de la Puente, P., Gnimpieba, E. Z., Miskimins, W. K., & Messerli, S. M.
(2022). Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC). Cancers, 14(7), 1753.
https://doi.org/10.3390/cancers14071753
